- EXAS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $44.7 million.
- EXAS has traded 14,276 shares today.
- EXAS is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in EXAS with the Ticky from Trade-Ideas. See the FREE profile for EXAS NOW at Trade-Ideas More details on EXAS: Exact Sciences Corporation, a molecular diagnostics company, focuses on developing non-invasive colorectal cancer screening products. Currently there are 8 analysts that rate Exact a buy, 1 analyst rates it a sell, and 3 rate it a hold. The average volume for Exact has been 1.4 million shares per day over the past 30 days. Exact has a market cap of $2.5 billion and is part of the health care sector and health services industry. The stock has a beta of 0.61 and a short float of 37.7% with 20.29 days to cover. Shares are up 6.7% year-to-date as of the close of trading on Friday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.